CELLTRION, is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion’s founder, Jung Jin Seo, is the richest person in South Korea. Their official website is CELLTRION.com.
A directory of user manuals and instructions for CELLTRION products can be found below. CELLTRION products are patented and trademarked under the brand Celltrion, Inc.
The CELLTRION CT-P60 COVID-19 IgG Rapid Test is an in vitro diagnostic test for use under Emergency Use Authorization. This user manual provides detailed instructions for the use of the CT-P60 kit, including preparation before testing and technical assistance. The test is authorized for detecting IgG antibodies to SARS-CoV-2 and is not FDA approved for any other viruses or pathogens. The user should be trained in the procedure and wear appropriate protective attire. False positive results may occur, and second confirmation tests are recommended.
CELLTRION DiaTrust COVID-19 Ag Rapid Test is a lateral flow immunoassay for detecting SARS-CoV-2 antigens in human nasopharyngeal swab specimens. This test is authorized for use in CLIA-certified laboratories and POC settings. Positive results require clinical correlation for infection confirmation.
The Celltrion DiaTrust COVID-19 Ag Home Test is a lateral flow immunoassay authorized for non-prescription home use to detect SARS-CoV-2 nucleocapsid protein and receptor binding domain in mid-turbinate swabs. This user manual provides instructions for use and interpretation of results. Important information on clinical correlation and follow-up care is included.
Learn about the Celltrion DiaTrust COVID-19 Ag Home Test, an in vitro diagnostic test for the qualitative detection of SARS-CoV-2 antigens in mid-turbinate swabs from individuals aged 14 years or older. This lateral flow immunoassay is authorized for non-prescription home use with self-collected and adult-collected direct mid-turbinate swab samples. Results indicate the presence of viral antigens and should be considered in the context of an individual's recent exposures, history, and symptoms.
